Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (40)
Prescription medicine registration (8)
Cancellation by sponsor (6)
Designation or determination (2)
Australian Public Assessment Report (AusPAR) (1)

Date

2026 (5)
2025 (7)
2024 (7)
2022 (2)
2021 (1)
2019 (1)
2018 (2)
2017 (6)
2016 (6)
2012 (4)
2010 (4)
2009 (2)
2008 (1)
2007 (4)
2006 (5)

Search

Sponsor content

57 result(s) found, displaying 31 to 40

BRIVIACT brivaracetam 50mg film-coated tablets blister pack (243797)

4 August 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BRIVIACT brivaracetam 50mg film-coated tablets blister pack.
VIMPAT (UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia)

25 July 2018

Prescription medicine registration

Active ingredients: lacosamide.
KEPPRA levetiracetam 500 mg/ 5 mL concentrate for infusion vial Cancelled under s30(1)(c)

10 October 2017

Cancellation by sponsor

Requested by UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
KEPCET levetiracetam 250mg tablet - film coated blister pack Cancelled under s30(1)(c)

10 October 2017

Cancellation by sponsor

Requested by UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
KEPCET levetiracetam 500mg tablet - film coated blister pack Cancelled under s30(1)(c)

10 October 2017

Cancellation by sponsor

Requested by UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
KEPCET levetiracetam 750mg tablet - film coated blister pack Cancelled under s30(1)(c)

10 October 2017

Cancellation by sponsor

Requested by UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
KEPCET levetiracetam 1000mg tablet - film coated blister pack Cancelled under s30(1)(c)

10 October 2017

Cancellation by sponsor

Requested by UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
VIMPAT lacosamide 100 mg film-coated tablets blister pack (196450)

31 July 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VIMPAT lacosamide 100 mg film-coated tablets blister pack.
VIMPAT lacosamide 50 mg film-coated tablets blister pack (196449)

31 July 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VIMPAT lacosamide 50 mg film-coated tablets blister pack.
VIMPAT lacosamide 200 mg film-coated tablets blister pack (196452)

31 July 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VIMPAT lacosamide 200 mg film-coated tablets blister pack.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.